SION – sionna therapeutics, inc. (US:NASDAQ)

News

Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? [Yahoo! Finance]
Hot Picks: Biotech picks target cystic fibrosis trials and rare-disease drugs [BNN Bloomberg (Canada)]
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares [Yahoo! Finance]
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com